» Deals & Alliances

Portola Pharmaceuticals Gets $50M Upfront from Merck (Take the Poll)


July 9, 2009 at 10:14 am EST | <> Add A Comment |

It’s Over: Novartis Ends NexMed Antifungal Deal


July 7, 2009 at 6:12 pm EST | <> Add A Comment |

After All the Rumors, it’s J&J for Elan (Two Deals in Two Days!)


July 2, 2009 at 1:57 pm EST | <> Add A Comment |

New JV: Good for Maxygen Shareholders, Bad for Employees


July 1, 2009 at 4:49 pm EST | <> Add A Comment |

Acorda, Biogen in Ex-U.S. Deal for Fampridine-SR; No U.S.?


July 1, 2009 at 9:37 am EST | <> Add A Comment |

Chroma Therapeutics in Deal with GSK, Raises $24 Million


June 23, 2009 at 11:16 am EST | <> Add A Comment |

Boehringer Ingelheim, Ipsen Get Deals Done


June 15, 2009 at 12:53 pm EST | <> Add A Comment |

Pfizer, GSK: The Race for Emerging Markets


June 15, 2009 at 10:17 am EST | <> Add A Comment |

Bayhill Therapeutics Gets $25M Upfront from Genentech


June 10, 2009 at 5:16 pm EST | <> 1 Comment |

Pfizer to Goldman: This Off-Patent Drug Market is Big!


June 10, 2009 at 1:12 pm EST | <> 1 Comment |

Novartis’ Daniel Vasella Might Say “No Thanks” to Alcon


June 3, 2009 at 11:05 am EST | <> Add A Comment |

Millennium Pharmaceuticals CEO: Smaller Drug Companies “Delusional”


June 2, 2009 at 1:21 pm EST | <> Add A Comment |

Concert Pharmaceuticals in $1B Deal with GSK


June 2, 2009 at 10:31 am EST | <> Add A Comment |

European Biotechs – Always a Bridesmaid, Never a Bride


May 30, 2009 at 1:21 pm EST | <> Add A Comment |

Genta’s Tesetaxel – Hype or Truth?


May 28, 2009 at 9:50 pm EST | <> 1 Comment |